Lifeward Ltd (LFWD)

$6.53 +0.05 (0.69%)
Market Cap 9.78M
Revenue (ttm) 22.03M
Net Income (ttm) -19.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -90.38%
Debt to Equity Ratio 0.33
Volume 9,748
Avg Vol 10,346
Day's Range N/A - N/A
Shares Out 1.53M
Stochastic %K 16%
Beta 0.32
Analysts Strong Sell
Price Target $10.00

Company Profile

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 4 959 0123
Address:
3 Hatnufa St., 6th floor P.O. Box 161, Yokneam Illit, Israel
EvE12
EvE12 May. 13 at 6:42 AM
$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-report-first-quarter-2026-financial-results-may-15-2026
0 · Reply
dogeedayafternoon
dogeedayafternoon May. 12 at 2:21 PM
$LFWD
0 · Reply
Kjskms
Kjskms May. 5 at 9:05 AM
$LFWD Come up a bit, you idiot.
0 · Reply
Kjskms
Kjskms May. 4 at 3:02 PM
$LFWD Proud Israel!!
0 · Reply
traderNo1
traderNo1 Apr. 30 at 3:06 PM
$LFWD decades of fooled investors… this is Larry Jasinski’s last gift after fooling and fooling investors for decades. Sorry for you whoever lost.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 28 at 2:03 PM
$LFWD RSI: 58.56, MACD: 0.2011 Vol: 0.41, MA20: 6.93, MA50: 6.59 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Kjskms
Kjskms Apr. 10 at 2:44 PM
$LFWD $0.50 before the reverse split. It's embarrassing and humiliating. This is your true value.
0 · Reply
BleedinJaysus
BleedinJaysus Apr. 10 at 11:36 AM
$LFWD hmmm to buy or not to buy. This thing actually have any promise ?
0 · Reply
HappyGentelmen
HappyGentelmen Mar. 25 at 9:07 PM
$LFWD target for the next days?
2 · Reply
EvE12
EvE12 Mar. 25 at 8:51 PM
$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-successfully-closes-strategic-partnership-oramed
0 · Reply
Latest News on LFWD
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026

May 11, 2026, 9:25 AM EDT - 2 days ago

Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026

Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton

May 4, 2026, 8:00 AM EDT - 9 days ago

Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton

Lifeward files to sell 7.26M ordinary shares for holders

2026-04-27T21:05:12.000Z - 15 days ago

Lifeward files to sell 7.26M ordinary shares for holders

Lifeward closes strategic partnership agreement with Oramed

2026-03-25T20:45:17.000Z - 6 weeks ago

Lifeward closes strategic partnership agreement with Oramed

ORMP

Lifeward Successfully Closes on Strategic Partnership with Oramed

Mar 25, 2026, 4:10 PM EDT - 6 weeks ago

Lifeward Successfully Closes on Strategic Partnership with Oramed

Lifeward price target adjusted to $10 from $4.50 at H.C. Wainwright

2026-03-19T10:12:03.000Z - 7 weeks ago

Lifeward price target adjusted to $10 from $4.50 at H.C. Wainwright

Lifeward Earnings Call Transcript: Q4 2025

Mar 18, 2026, 8:30 AM EDT - 2 months ago

Lifeward Earnings Call Transcript: Q4 2025

Lifeward reports Q4 adjusted EPS ($2.85) vs. ($4.54) last year

2026-03-18T12:11:03.000Z - 2 months ago

Lifeward reports Q4 adjusted EPS ($2.85) vs. ($4.54) last year

Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 18, 2026, 8:00 AM EDT - 2 months ago

Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results

Lifeward receives shareholder approval to close on partnership with Oramed

2026-03-13T12:23:55.000Z - 2 months ago

Lifeward receives shareholder approval to close on partnership with Oramed

ORMP

Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company

Mar 13, 2026, 8:00 AM EDT - 2 months ago

Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company

ORMP

Lifeward regains compliance with Nasdq minimum bid price requirement

2026-03-11T12:15:27.000Z - 2 months ago

Lifeward regains compliance with Nasdq minimum bid price requirement

Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement

Mar 11, 2026, 8:00 AM EDT - 2 months ago

Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement

Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Mar 10, 2026, 4:15 PM EDT - 2 months ago

Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Lifeward announces collaboration with Shirley Ryan AbilityLab

2026-03-02T13:36:22.000Z - 2 months ago

Lifeward announces collaboration with Shirley Ryan AbilityLab

Lifeward announces collaboration with Shirley Ryan AbilityLab

2026-03-02T13:29:53.000Z - 2 months ago

Lifeward announces collaboration with Shirley Ryan AbilityLab

Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton

Mar 2, 2026, 8:00 AM EST - 2 months ago

Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton

Lifeward to acquire assets, technology from Skelable for $480k

2026-02-25T13:18:06.000Z - 2 months ago

Lifeward to acquire assets, technology from Skelable for $480k

Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors

Feb 25, 2026, 8:00 AM EST - 2 months ago

Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors

Lifeward announces 1-for-12 reverse stock split

2026-02-20T13:06:48.000Z - 2 months ago

Lifeward announces 1-for-12 reverse stock split

Lifeward Announces Reverse Share Split

Feb 20, 2026, 8:00 AM EST - 2 months ago

Lifeward Announces Reverse Share Split

Lifeward’s ReWalk Personal Exoskeleton covered by Aetna

2026-02-17T13:21:32.000Z - 3 months ago

Lifeward’s ReWalk Personal Exoskeleton covered by Aetna

Lifeward's ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

Feb 17, 2026, 8:00 AM EST - 3 months ago

Lifeward's ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

Oramed and Lifeward sign strategic transaction

2026-01-13T13:05:41.000Z - 4 months ago

Oramed and Lifeward sign strategic transaction

ORMP

Lifeward enters investment, partnership agreement with Oramed

2026-01-13T13:05:14.000Z - 4 months ago

Lifeward enters investment, partnership agreement with Oramed

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

Jan 13, 2026, 8:00 AM EST - 4 months ago

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

ORMP

Oramed and Lifeward Announce Strategic Transaction

Jan 13, 2026, 7:58 AM EST - 4 months ago

Oramed and Lifeward Announce Strategic Transaction

ORMP

Lifeward chairman Joseph Turk to depart, Lantheus CFO Bob Marshall to succeed

2025-12-19T21:15:17.000Z - 5 months ago

Lifeward chairman Joseph Turk to depart, Lantheus CFO Bob Marshall to succeed

LNTH

Lifeward Appoints Bob Marshall as Chairman of the Board

Dec 19, 2025, 4:05 PM EST - 5 months ago

Lifeward Appoints Bob Marshall as Chairman of the Board

Lifeward expands international distribution of ReWalk Personal Exoskeleton

2025-12-17T13:11:37.000Z - 5 months ago

Lifeward expands international distribution of ReWalk Personal Exoskeleton

Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates

Dec 17, 2025, 8:00 AM EST - 5 months ago

Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates

Lifeward broadens coverage for ReWalk 7 Personal Robotic Exoskeleton

2025-12-03T13:20:10.000Z - 5 months ago

Lifeward broadens coverage for ReWalk 7 Personal Robotic Exoskeleton

UNH

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

Dec 3, 2025, 8:00 AM EST - 5 months ago

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

Lifeward price target lowered to $4.50 from $13 at H.C. Wainwright

2025-11-18T11:11:03.000Z - 6 months ago

Lifeward price target lowered to $4.50 from $13 at H.C. Wainwright

Lifeward receives prior authorization from UnitedHealthcare for ReWalk 7

2025-11-17T13:10:29.000Z - 6 months ago

Lifeward receives prior authorization from UnitedHealthcare for ReWalk 7

UNH

UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton

Nov 17, 2025, 8:00 AM EST - 6 months ago

UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton

Lifeward Earnings Call Transcript: Q3 2025

Nov 14, 2025, 8:30 AM EST - 6 months ago

Lifeward Earnings Call Transcript: Q3 2025

Lifeward Ltd. Reports Third Quarter 2025 Financial Results

Nov 14, 2025, 8:00 AM EST - 6 months ago

Lifeward Ltd. Reports Third Quarter 2025 Financial Results

Lifeward to Report Third Quarter Financial Results on November 14, 2025

Nov 10, 2025, 7:00 AM EST - 6 months ago

Lifeward to Report Third Quarter Financial Results on November 14, 2025

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton

Sep 9, 2025, 8:30 AM EDT - 8 months ago

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

Sep 8, 2025, 8:30 AM EDT - 8 months ago

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

Lifeward Earnings Call Transcript: Q2 2025

Aug 14, 2025, 8:30 AM EDT - 9 months ago

Lifeward Earnings Call Transcript: Q2 2025

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 8:00 AM EDT - 9 months ago

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership

Aug 13, 2025, 8:00 AM EDT - 9 months ago

Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership

Lifeward to Report Second Quarter Financial Results on August 14, 2025

Aug 7, 2025, 5:30 PM EDT - 9 months ago

Lifeward to Report Second Quarter Financial Results on August 14, 2025

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region

Aug 4, 2025, 8:30 AM EDT - 10 months ago

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region

MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion

Jul 7, 2025, 11:00 AM EDT - 11 months ago

MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion

Lifeward Announces Closing of $2.6 Million Public Offering

Jun 26, 2025, 4:15 PM EDT - 11 months ago

Lifeward Announces Closing of $2.6 Million Public Offering

Lifeward Announces Pricing of $2.6 Million Public Offering

Jun 25, 2025, 9:10 AM EDT - 11 months ago

Lifeward Announces Pricing of $2.6 Million Public Offering

Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary

Jun 24, 2025, 4:05 PM EDT - 11 months ago

Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary

Lifeward Transcript: Sidoti May Micro-Cap Virtual Conference

May 21, 2025, 10:00 AM EDT - 1 year ago

Lifeward Transcript: Sidoti May Micro-Cap Virtual Conference

Lifeward Names Mark Grant as New CEO

May 19, 2025, 8:30 AM EDT - 1 year ago

Lifeward Names Mark Grant as New CEO

Lifeward to Present at Sidoti Virtual Investor Conference on May 21

May 19, 2025, 6:00 AM EDT - 1 year ago

Lifeward to Present at Sidoti Virtual Investor Conference on May 21

Lifeward Earnings Call Transcript: Q1 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

Lifeward Earnings Call Transcript: Q1 2025

Lifeward Ltd. Reports First Quarter 2025 Financial Results

May 15, 2025, 8:00 AM EDT - 1 year ago

Lifeward Ltd. Reports First Quarter 2025 Financial Results

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons

May 8, 2025, 8:30 AM EDT - 1 year ago

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Apr 29, 2025, 8:30 AM EDT - 1 year ago

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton

Apr 24, 2025, 8:30 AM EDT - 1 year ago

Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton

Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

Apr 15, 2025, 8:15 AM EDT - 1 year ago

Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

FDA Issues Clearance for ReWalk 7 Exoskeleton

Mar 13, 2025, 9:15 AM EDT - 1 year ago

FDA Issues Clearance for ReWalk 7 Exoskeleton

Lifeward Earnings Call Transcript: Q4 2024

Mar 7, 2025, 8:30 AM EST - 1 year ago

Lifeward Earnings Call Transcript: Q4 2024

Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 7, 2025, 8:00 AM EST - 1 year ago

Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results

Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton

Mar 6, 2025, 8:00 AM EST - 1 year ago

Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton

Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

Mar 5, 2025, 8:00 AM EST - 1 year ago

Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

Feb 28, 2025, 8:00 AM EST - 1 year ago

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

Lifeward Announces CEO Transition

Feb 19, 2025, 9:10 AM EST - 1 year ago

Lifeward Announces CEO Transition

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Jan 13, 2025, 8:30 AM EST - 1 year ago

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Jan 13, 2025, 7:45 AM EST - 1 year ago

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 8, 2025, 4:15 PM EST - 1 year ago

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 7, 2025, 8:05 AM EST - 1 year ago

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Dec 27, 2024, 5:49 PM EST - 1 year ago

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Nov 19, 2024, 8:30 AM EST - 1 year ago

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Lifeward Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Lifeward Earnings Call Transcript: Q3 2024

Lifeward Ltd. Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 8:00 AM EST - 1 year ago

Lifeward Ltd. Reports Third Quarter 2024 Financial Results

EvE12
EvE12 May. 13 at 6:42 AM
$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-report-first-quarter-2026-financial-results-may-15-2026
0 · Reply
dogeedayafternoon
dogeedayafternoon May. 12 at 2:21 PM
$LFWD
0 · Reply
Kjskms
Kjskms May. 5 at 9:05 AM
$LFWD Come up a bit, you idiot.
0 · Reply
Kjskms
Kjskms May. 4 at 3:02 PM
$LFWD Proud Israel!!
0 · Reply
traderNo1
traderNo1 Apr. 30 at 3:06 PM
$LFWD decades of fooled investors… this is Larry Jasinski’s last gift after fooling and fooling investors for decades. Sorry for you whoever lost.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 28 at 2:03 PM
$LFWD RSI: 58.56, MACD: 0.2011 Vol: 0.41, MA20: 6.93, MA50: 6.59 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Kjskms
Kjskms Apr. 10 at 2:44 PM
$LFWD $0.50 before the reverse split. It's embarrassing and humiliating. This is your true value.
0 · Reply
BleedinJaysus
BleedinJaysus Apr. 10 at 11:36 AM
$LFWD hmmm to buy or not to buy. This thing actually have any promise ?
0 · Reply
HappyGentelmen
HappyGentelmen Mar. 25 at 9:07 PM
$LFWD target for the next days?
2 · Reply
EvE12
EvE12 Mar. 25 at 8:51 PM
$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-successfully-closes-strategic-partnership-oramed
0 · Reply
Kjskms
Kjskms Mar. 25 at 11:27 AM
$LFWD South Korea's Samchundang Pharmaceutical makes it happen with oral insulin.
0 · Reply
Kjskms
Kjskms Mar. 24 at 12:05 PM
$LFWD How many decades have you been toying with the shareholders?
1 · Reply
NASDboy
NASDboy Mar. 23 at 5:25 PM
$LFWD comes free with your purchase!
0 · Reply
Kjskms
Kjskms Mar. 23 at 11:03 AM
$LFWD A stupid deficit company
0 · Reply
Kjskms
Kjskms Mar. 19 at 7:21 AM
$LFWD Sell ​​off all the failing businesses. What kind of stubbornness is this?
1 · Reply
mezquita
mezquita Mar. 18 at 3:14 PM
$LFWD The same thing every quarter: monkeys in charge of a company that could be incredible.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 18 at 2:09 PM
$LFWD Q4 '25 Earnings Results & Recap Lifeward's Q4 2025 revenue decreased 33% to $5.1M, and GAAP net loss narrowed 65% to $5.3M from Q4 2024. Full year 2025 revenue declined 14% to $22M.
0 · Reply
Kjskms
Kjskms Mar. 18 at 1:40 PM
$LFWD I knew that would happen
0 · Reply
EvE12
EvE12 Mar. 18 at 1:19 PM
$LFWD Omg, Mark WTF? Where is Larry??
0 · Reply
EvE12
EvE12 Mar. 18 at 12:23 PM
$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-reports-fourth-quarter-and-full-year-2025-financial
0 · Reply
NASDboy
NASDboy Mar. 14 at 4:46 PM
$LFWD gurus on X , threads, and IG pumping this
1 · Reply
emailsl
emailsl Mar. 13 at 9:21 PM
$LFWD
0 · Reply